Modifiable Risk Factors for Breast Cancer Mortality in Türkiye from 1990 to 2019: A Temporal Analysis of Global Burden of Disease Data

Overview

Journal Balkan Med J

Publisher Galenos Publishing House

Specialty General Medicine

Date 2024 Jul 5

PMID 38966919

Authors

Ali Cem Yekdes

Didem Han Yekdes

Ulfiye Celikkalp

Galip Ekuklu

Affiliations

Soon will be listed here.

Abstract

Background: Breast cancer is the leading cause of cancer-related mortality in women in Türkiye.

Aims: Explore the trends in female breast cancer mortality rates and the associated modifiable factors in Türkiye between 1990 and 2019.

Study Design: Epidemiological descriptive analysis.

Methods: The database of the Global Burden of Disease study was used to obtain data regarding breast cancer-related mortality and modifiable (behavioral and metabolic) risk factors among women in Türkiye from 1990 to 2019. The average annual percentage change (AAPC) for female breast cancer mortality rates was computed using the Joinpoint regression method.

Results: From 1990 to 2009, the breast cancer mortality rates in Türkiye tended to increase [from 12.26/105 in 1990 to 12.65/105 in 2019; AAPC=0.1 "95% confidence interval (CI): 0.1-0.1"]. In terms of breast cancer mortality attributed to modifiable factors, a 3% increase was observed from 1990 (20.4%) to 2019 (23.1%), the highest contributor being high body mass index (3.19% in 1990 to 5.87% in 2019; AAPC=1.5; 95% CI: 1.3-1.5), followed by high fasting plasma glucose (5.01% in 1990 to 7.72% in 2019; AAPC=1.4; 95% CI: 1.3-1.5).

Conclusion: The proportion of breast cancer-related deaths attributed to metabolic factors has been increasing in Türkiye from 1990 to 2019. Therefore, health policies aimed at managing metabolic factors in women are warranted to reduce breast cancer-related mortality in Türkiye.

References

Protani M, Coory M, Martin J . Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010; 123(3):627-35. DOI: 10.1007/s10549-010-0990-0. View

Mahamat-Saleh Y, Rinaldi S, Kaaks R, Biessy C, Gonzalez-Gil E, Murphy N . Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 2023; 12(11):12668-12682. PMC: 10278526. DOI: 10.1002/cam4.5896. View

Chen W, Rosner B, Hankinson S, Colditz G, Willett W . Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA. 2011; 306(17):1884-90. PMC: 3292347. DOI: 10.1001/jama.2011.1590. View

Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S . Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care. 2002; 25(9):1551-6. DOI: 10.2337/diacare.25.9.1551. View

Tari Selcuk K, Avci D, Yilmaz Dundar G, Mercan Y . Breast Cancer Screening Behaviors in Women Aged 40 Years and Over in a Semi-Urban Region in Turkey: Relationships with Health Beliefs. Healthcare (Basel). 2020; 8(2). PMC: 7349266. DOI: 10.3390/healthcare8020171. View

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M . Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018; 391(10125):1023-1075. PMC: 5879496. DOI: 10.1016/S0140-6736(17)33326-3. View

Dossus L, Boutron-Ruault M, Kaaks R, Gram I, Vilier A, Fervers B . Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort. Int J Cancer. 2014; 134(8):1871-88. DOI: 10.1002/ijc.28508. View

Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019; 5(12):1749-1768. PMC: 6777271. DOI: 10.1001/jamaoncol.2019.2996. View

Ozdemir R, Rao C, Ocek Z, Dinc Horasan G . Reliable mortality statistics for Turkey: Are we there yet?. BMC Public Health. 2015; 15:545. PMC: 4460716. DOI: 10.1186/s12889-015-1904-1. View

10.

de Boer M, Worner E, Verlaan D, van Leeuwen P . The Mechanisms and Effects of Physical Activity on Breast Cancer. Clin Breast Cancer. 2017; 17(4):272-278. DOI: 10.1016/j.clbc.2017.01.006. View

11.

Luleci D, Kilic B . Factors Affecting Women's Participation in Breast Cancer Screening in Turkey. Asian Pac J Cancer Prev. 2022; 23(5):1627-1634. PMC: 9587867. DOI: 10.31557/APJCP.2022.23.5.1627. View

12.

Xu S, Liu Y, Zhang T, Zheng J, Lin W, Cai J . The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019. Front Oncol. 2021; 11:689562. PMC: 8176863. DOI: 10.3389/fonc.2021.689562. View

13.

Janssen F, Kunst A . ICD coding changes and discontinuities in trends in cause-specific mortality in six European countries, 1950-99. Bull World Health Organ. 2005; 82(12):904-13. PMC: 2623106. DOI: /S0042-96862004001200006. View

14.

. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1204-1222. PMC: 7567026. DOI: 10.1016/S0140-6736(20)30925-9. View

15.

Li N, Deng Y, Zhou L, Tian T, Yang S, Wu Y . Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017. J Hematol Oncol. 2019; 12(1):140. PMC: 6925497. DOI: 10.1186/s13045-019-0828-0. View

16.

Azamjah N, Soltan-Zadeh Y, Zayeri F . Global Trend of Breast Cancer Mortality Rate: A 25-Year Study. Asian Pac J Cancer Prev. 2019; 20(7):2015-2020. PMC: 6745227. DOI: 10.31557/APJCP.2019.20.7.2015. View

17.

Ozmen V, Ozmen T, Dogru V . Breast Cancer in Turkey; An Analysis of 20.000 Patients with Breast Cancer. Eur J Breast Health. 2019; 15(3):141-146. PMC: 6619786. DOI: 10.5152/ejbh.2019.4890. View

18.

Ozdemir R, Dinc Horasan G, Rao C, Sozmen M, Unal B . An evaluation of cause-of-death trends from recent decades based on registered deaths in Turkey. Public Health. 2017; 151:121-130. DOI: 10.1016/j.puhe.2017.07.006. View

19.

Kim H, Fay M, Feuer E, Midthune D . Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3):335-51. DOI: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z. View

20.

Anderson E, Durstine J . Physical activity, exercise, and chronic diseases: A brief review. Sports Med Health Sci. 2022; 1(1):3-10. PMC: 9219321. DOI: 10.1016/j.smhs.2019.08.006. View